Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against <i>Toxoplasma gondii</i>

Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against <i>Toxoplasma gondii</i>

<i>Toxoplasma gondii</i> is a protozoan that infects up to a third of the world’s population. This parasite can cause serious problems, especially if a woman is infected during pregnancy, when toxoplasmosis can cause miscarriage, or serious complications to the baby, or in an immunocompr...

Full description

Bibliographic Details
Main Authors: Débora Chaves Cajazeiro, Paula Pereira Marques Toledo, Natália Ferreira de Sousa, Marcus Tullius Scotti, Juliana Quero Reimão
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
bioinformatics
drug repurposing
toxoplasmosis
<i>Toxoplasma gondii</i>
in vitro screening
drug targets
Online Access:https://www.mdpi.com/1999-4923/14/8/1634

Internet

https://www.mdpi.com/1999-4923/14/8/1634

Similar Items